Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Asset Utilization Ratio (2016 - 2025)

Guided Therapeutics' Asset Utilization Ratio history spans 14 years, with the latest figure at 0.19 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 535.41% year-over-year to 0.19; the TTM value through Sep 2025 reached 0.19, up 535.41%, while the annual FY2024 figure was 0.0, 88.2% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.19 at Guided Therapeutics, up from 0.12 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.19 in Q3 2025 and bottomed at 0.0 in Q1 2025.
  • The 5-year median for Asset Utilization Ratio is 0.03 (2023), against an average of 0.04.
  • The largest annual shift saw Asset Utilization Ratio surged 1438.52% in 2023 before it crashed 98.36% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2021, then plummeted by 91.61% to 0.0 in 2022, then soared by 1438.52% to 0.06 in 2023, then crashed by 90.36% to 0.01 in 2024, then skyrocketed by 3524.57% to 0.19 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Asset Utilization Ratio are 0.19 (Q3 2025), 0.12 (Q2 2025), and 0.0 (Q1 2025).